Marshall Wace’s Varex Imaging VREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Sell
178,377
-34,564
-16% -$373K ﹤0.01% 1906
2026
Q1
$2.26M Buy
212,941
+36,400
+21% +$465K ﹤0.01% 1717
2025
Q4
$2.06M Sell
176,541
-4,400
-2% -$51.5K ﹤0.01% 1569
2025
Q3
$2.24M Buy
+180,941
New +$1.79M ﹤0.01% 1562
2025
Q2
Sell
-247,584
Closed -$2.87M 3221
2025
Q1
$2.87M Buy
247,584
+232,227
+1,512% +$3.07M ﹤0.01% 1307
2024
Q4
$224K Buy
+15,357
New +$215K ﹤0.01% 2321
2023
Q4
Sell
-136,551
Closed -$2.57M 2645
2023
Q3
$2.57M Buy
+136,551
New +$2.86M 0.01% 1109
2022
Q2
Sell
-135,365
Closed -$2.88M 3891
2022
Q1
$2.88M Sell
135,365
-78,370
-37% -$1.99M 0.01% 1816
2021
Q4
$6.74M Buy
+213,735
New +$6.06M 0.01% 1154
2019
Q4
Sell
-24,299
Closed -$693K 2092
2019
Q3
$693K Sell
24,299
-30,437
-56% -$881K 0.01% 1023
2019
Q2
$1.68M Buy
+54,736
New +$1.67M 0.01% 816
2019
Q1
Sell
-238,495
Closed -$5.65M 2081
2018
Q4
$5.65M Buy
+238,495
New +$6.06M 0.06% 413

Other funds holding VREX

Marshall Wace's VREX Position: Q2 2026 in Review

Marshall Wace reduced its Varex Imaging (VREX) stake by 16% in Q2 2026, selling an estimated $373K and leaving 178,377 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1906.

Marshall Wace first reported a position in VREX in Q4 2018 and has held it in 12 quarters since. The position peaked at $6.74M in Q4 2021. 187 funds tracked by Wall St. Rank hold VREX as of Q2 2026.

  • Marshall Wace held 178,377 shares of Varex Imaging worth $1.86M as of Q2 2026.
  • Marshall Wace sold 34,564 Varex Imaging shares in Q2 2026, an estimated $373K.
  • Varex Imaging made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1906 holding.
  • Marshall Wace first reported a position in Varex Imaging in Q4 2018 and has held it in 12 quarters since.
  • Marshall Wace's Varex Imaging position peaked at $6.74M in Q4 2021.
  • 187 funds tracked by Wall St. Rank held Varex Imaging as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.